{"DataElement":{"publicId":"2546687","version":"1","preferredName":"Protocol Radiation Therapy Administered Interval","preferredDefinition":"a specified time-period, defined by clinical trial procedures, when therapeutic application of radiation is given to treat tumor (cancer) and associated malignant tissue.","longName":"PROT_RT_ADM_INR","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2192281","version":"1","preferredName":"Protocol Radiation Therapy Administered","preferredDefinition":"related to the therapeutic application of radiation, proscribed by clinical trial procedures, used to treat malignant tumor (cancer) and associated malignant tissue.","longName":"PROT_RT_ADM","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2546686","version":"1","preferredName":"Protocol Radiation Therapy","preferredDefinition":"A protocol is a rule which guides how an activity should be performed; a set of formal rules used to specify the format of an exchange of data.:use PHOTOTHERAPY, LASER THERAPY, or ULTRAVIOLET THERAPY for therapeutic radiation with visible, laser, or ultraviolet light, respectively.","longName":"C42651:C15313","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Protocol","conceptCode":"C42651","definition":"A rule which guides how an activity should be performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Radiation Therapy","conceptCode":"C15313","definition":"Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"22DADF77-EDEA-50BC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-22","endDate":null,"createdBy":"PWEST","dateCreated":"2006-11-22","modifiedBy":"ONEDATA","dateModified":"2006-11-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177665","version":"1","preferredName":"Administered","preferredDefinition":"Given.","longName":"Administered","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-516D-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E9154C85-8A67-0576-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-17","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-11-17","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"updated OC to include qualifier term (already shown in DEC name)","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2546657","version":"1","preferredName":"Protocol Radiation Therapy Administered Interval","preferredDefinition":"a specified time-period, defined by clinical trial procedures, when therapeutic application of radiation is given to treat tumor (cancer) and associated malignant tissue.","longName":"PROT_RT_ADM_INR","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Prior to chemotherapy","valueDescription":"BEFORE CHEMOTHERAPY","ValueMeaning":{"publicId":"2582131","version":"1","preferredName":"BEFORE CHEMOTHERAPY","longName":"2582131v1.00","preferredDefinition":"Earlier in time or order._The use of synthetic or naturally-occurring chemicals for the treatment of diseases.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Chemotherapy","conceptCode":"C15632","definition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0DE0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-22","endDate":null,"createdBy":"PWEST","dateCreated":"2006-11-22","modifiedBy":"CLOHNES","dateModified":"2023-06-07","changeDescription":null,"administrativeNotes":"6/7/23 added concepts for VM per cleanup activities cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"22DC0DED-D565-43F4-E044-0003BA3F9857","beginDate":"2006-11-22","endDate":null,"createdBy":"PWEST","dateCreated":"2006-11-22","modifiedBy":"ONEDATA","dateModified":"2006-11-22","deletedIndicator":"No"},{"value":"Post chemotherapy","valueDescription":"Post-Chemotherapy","ValueMeaning":{"publicId":"2574830","version":"1","preferredName":"Post-Chemotherapy","longName":"2574830","preferredDefinition":"No Value Exists","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Post-chemotherapy","conceptCode":"C0439577","definition":"No Value Exists","evsSource":"UMLS_CUI","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F15B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-17","modifiedBy":"PWEST","dateModified":"2006-11-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"22DC223B-7437-56F9-E044-0003BA3F9857","beginDate":"2006-11-22","endDate":null,"createdBy":"PWEST","dateCreated":"2006-11-22","modifiedBy":"PWEST","dateModified":"2006-11-22","deletedIndicator":"No"},{"value":"At second cycle of protocol chemotherapy, without prior non-protocol chemotherapy","valueDescription":"At second cycle of protocol chemotherapy, without prior non-protocol chemotherapy.","ValueMeaning":{"publicId":"3631606","version":"1","preferredName":"At second cycle of protocol chemotherapy, without prior non-protocol chemotherapy.","longName":"3631606","preferredDefinition":"Radiation therapy will be started on Day 1 of second cycle of PROTOCOL chemotherapy, for patients with no prior protocol chemotherapy.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CFA99D3A-E635-077D-E040-BB89AD434F90","latestVersionIndicator":"Yes","beginDate":"2012-11-29","endDate":null,"createdBy":"LEUNGE","dateCreated":"2012-11-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CALGB CRF:Cancer and Leukemia Group B Case Report Form","id":"CFA99D3A-E64E-077D-E040-BB89AD434F90","beginDate":"2012-11-29","endDate":null,"createdBy":"LEUNGE","dateCreated":"2012-11-29","modifiedBy":"ONEDATA","dateModified":"2012-11-29","deletedIndicator":"No"},{"value":"At first cycle of protocol chemotherapy, without prior non-protocol chemotherapy","valueDescription":"At first cycle of protocol chemotherapy, without prior non-protocol chemotherapy","ValueMeaning":{"publicId":"3631607","version":"1","preferredName":"At first cycle of protocol chemotherapy, without prior non-protocol chemotherapy","longName":"3631607","preferredDefinition":"Radiation therapy will be started on Day 1 of first cycle of PROTOCOL chemotherapy, for patients with no prior protocol chemotherapy.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CFA99D3A-E658-077D-E040-BB89AD434F90","latestVersionIndicator":"Yes","beginDate":"2012-11-29","endDate":null,"createdBy":"LEUNGE","dateCreated":"2012-11-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CALGB CRF:Cancer and Leukemia Group B Case Report Form","id":"CFA99D3A-E671-077D-E040-BB89AD434F90","beginDate":"2012-11-29","endDate":null,"createdBy":"LEUNGE","dateCreated":"2012-11-29","modifiedBy":"ONEDATA","dateModified":"2012-11-29","deletedIndicator":"No"},{"value":"At first cycle of protocol chemotherapy, after one cycle of prior non-protocol chemotherapy","valueDescription":"At first cycle of protocol chemotherapy, after one cycle of prior non-protocol chemotherapy","ValueMeaning":{"publicId":"3631608","version":"1","preferredName":"At first cycle of protocol chemotherapy, after one cycle of prior non-protocol chemotherapy","longName":"3631608","preferredDefinition":"Radiation therapy  will be started on Day 1 of first cycle of PROTOCOL chemotherapy, for patients who had already received one cycle of study chemotherapy, prior to enrollment (This would actually correspond to second cycle of study chemotherapy received by the patient)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CFA99D3A-E67B-077D-E040-BB89AD434F90","latestVersionIndicator":"Yes","beginDate":"2012-11-29","endDate":null,"createdBy":"LEUNGE","dateCreated":"2012-11-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CALGB CRF:Cancer and Leukemia Group B Case Report Form","id":"CFA99D3A-E694-077D-E040-BB89AD434F90","beginDate":"2012-11-29","endDate":null,"createdBy":"LEUNGE","dateCreated":"2012-11-29","modifiedBy":"ONEDATA","dateModified":"2012-11-29","deletedIndicator":"No"},{"value":"Second Cycle","valueDescription":"Second Chemotherapy Cycle","ValueMeaning":{"publicId":"3484497","version":"1","preferredName":"Second Chemotherapy Cycle","longName":"3484497","preferredDefinition":"Coming next after the first in position in space or time or degree or magnitude.: The use of synthetic or naturally-occurring chemicals for the treatment of diseases.  Although this term may be used to describe any therapy involving the use of chemical-based agents, it is most commonly used to refer to the variety of chemical-based agents employed to treat cancer.  Cancer chemotherapy works by arresting or killing the growth and spread of cancer cells.  Because cancer cells usually divide much faster than normal cells, they are often very sensitive to the inhibitory actions of chemotherapeutic agents.  Chemotherapy may also include agents that enhance immune function or alter hormonal activity. (NCI04): An event or sequence of events that constitute round or succession of observable phenomena, recurring usually at regular or approximately regular time intervals and in the same sequence.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Second","conceptCode":"C25666","definition":"Coming next after the first in position in space or time or degree or magnitude.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Chemotherapy","conceptCode":"C15632","definition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cycle","conceptCode":"C25472","definition":"An event or sequence of events that constitute a round or succession of observable phenomena, recurring usually at regular or approximately regular time intervals and in the same sequence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C2EABB63-3E10-D0A9-E040-BB89AD43745C","latestVersionIndicator":"Yes","beginDate":"2012-06-20","endDate":null,"createdBy":"LEUNGE","dateCreated":"2012-06-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C2EABB63-3E29-D0A9-E040-BB89AD43745C","beginDate":"2012-06-20","endDate":null,"createdBy":"LEUNGE","dateCreated":"2012-06-20","modifiedBy":"ONEDATA","dateModified":"2012-06-20","deletedIndicator":"No"},{"value":"First Cycle","valueDescription":"First Chemotherapy Cycle","ValueMeaning":{"publicId":"3484498","version":"1","preferredName":"First Chemotherapy Cycle","longName":"3484498","preferredDefinition":"Preceding all others in time or space or degree.: The use of synthetic or naturally-occurring chemicals for the treatment of diseases.  Although this term may be used to describe any therapy involving the use of chemical-based agents, it is most commonly used to refer to the variety of chemical-based agents employed to treat cancer.  Cancer chemotherapy works by arresting or killing the growth and spread of cancer cells.  Because cancer cells usually divide much faster than normal cells, they are often very sensitive to the inhibitory actions of chemotherapeutic agents.  Chemotherapy may also include agents that enhance immune function or alter hormonal activity. (NCI04): An event or sequence of events that constitute round or succession of observable phenomena, recurring usually at regular or approximately regular time intervals and in the same sequence.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"First","conceptCode":"C25509","definition":"Preceding all others in time or space or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Chemotherapy","conceptCode":"C15632","definition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cycle","conceptCode":"C25472","definition":"An event or sequence of events that constitute a round or succession of observable phenomena, recurring usually at regular or approximately regular time intervals and in the same sequence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C2EABB63-3E37-D0A9-E040-BB89AD43745C","latestVersionIndicator":"Yes","beginDate":"2012-06-20","endDate":null,"createdBy":"LEUNGE","dateCreated":"2012-06-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C2EABB63-3E50-D0A9-E040-BB89AD43745C","beginDate":"2012-06-20","endDate":null,"createdBy":"LEUNGE","dateCreated":"2012-06-20","modifiedBy":"ONEDATA","dateModified":"2012-06-20","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008561","version":"1","preferredName":"Occurrences","preferredDefinition":"dates, times, and durations.","longName":"OCURS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B53BD1AB-090B-398B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-01-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2525196","version":"1","preferredName":"Interval","preferredDefinition":"The period of time or the distance separating two instances, events, or occurrences.","longName":"C25543","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Interval","conceptCode":"C25543","definition":"The period of time or the distance separating two instances, events, or occurrences.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"1EEC06BB-D10D-36EF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-03","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-10-03","modifiedBy":"ONEDATA","dateModified":"2006-10-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"22DAD10E-2106-4F24-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-22","endDate":null,"createdBy":"PWEST","dateCreated":"2006-11-22","modifiedBy":"LEUNGE","dateModified":"2012-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811831","version":"1","longName":"Breast","context":"CTEP"},{"publicId":"2811832","version":"1","longName":"Lung","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811963","version":"1","longName":"Treatment","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"When did the patient start re","type":"Preferred Question Text","description":"When did the patient start receiving radiation therapy as part of protocol treatment?","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Radiotherapy Start Time","url":null,"context":"CTEP"}],"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"22DC0B56-2FF8-43F2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-22","endDate":null,"createdBy":"PWEST","dateCreated":"2006-11-22","modifiedBy":"LEUNGE","dateModified":"2012-06-20","changeDescription":"Alternate Question Text (CRF Text 1) added for use in CALGB-30610 OPEN Registration Worksheet","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}